ResMed (NYSE: RMD) → Stock, financial statements
Advertising

ResMed: stocks, financial statements

Dividends News
Favorites

ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

  • RMD Ticker
  • NYSE Exchange
  • 5,940 Employees
3 rated

Financial statements — ResMed

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
3B 2.6B 2.3B 2.1B 1.8B
Cost Of Revenue
1.2B 1.1B 980M 860M 770M
Gross Profit
1.8B 1.5B 1.4B 1.2B 1.1B
Research and Development
200M 180M 160M 140M 120M
Selling General and Admin
680M 650M 600M 550M 490M
Operating Expense
2.2B 2B 1.8B 1.6B 1.4B
Operating Income
780M 620M 560M 460M 440M
Other Income Expense Net
0 0 0 0 0
EBIT
780M 620M 560M 460M 440M
Interest Income
39M 34M 12M 11M -5.7M
Pretax Income
730M 520M 520M 420M 440M
Income Tax
110M 110M 210M 76M 87M
Minority Interest
0 0 0 0 0
Net Income
620M 400M 320M 340M 350M
Net Income Basic
620M 400M 320M 340M 350M
20 ← 16 2020 2019 2018 2017 2016
Current cash
460M 150M 190M 820M 730M
Short term investments
170M 120M 120M 100M 82M
Receivables
470M 530M 480M 450M 380M
Inventory
420M 350M 270M 270M 220M
Other current assets
170M 120M 120M 100M 82M
Current assets
1.5B 1.1B 1.1B 1.6B 1.4B
Long term investments
3.1B 3B 2B 1.8B 1.8B
Property plant equipment
420M 390M 390M 390M 380M
Goodwill
1.9B 1.9B 1.1B 1.1B 1.1B
Intangible assets
450M 520M 220M 260M 300M
Other assets
100M 99M 230M 3.7M 6.6M
Total assets
4.6B 4.1B 3.1B 3.5B 3.3B
Accounts payable
140M 120M 93M 93M 93M
Current long term debt
12M 12M 11M 0 300M
Other current liabilities
450M 430M 410M 270M 250M
Total current liabilities
600M 560M 510M 360M 640M
Long term debt
1.2B 1.3B 270M 1.1B 880M
Other liabilities
210M 210M 210M 56M 41M
Minority Interest
0 0 0 0 0
Total Liabilities
2.1B 2B 1B 1.5B 1.6B
Common stock
140M 140M 140M 140M 140M
Retained earning
2.8B 2.4B 2.4B 2.3B 2.2B
Treasury stock
-1.6B -1.6B -1.6B -1.5B -1.5B
Capital surplus
Shareholder equity
2.5B 2.1B 2.1B 2B 1.7B
Net tangible assets
160M -310M 770M 630M 340M
20 ← 16 2020 2019 2018 2017 2016
Net Income
620M 400M 320M 340M 350M
Depreciation
180M 150M 120M 110M 87M
Changes in receivables
-54M 45M 33M 68M 20M
Changes in inventories
67M 81M 380K 44M -22M
Cash change
320M -42M -630M 91M 14M
Cash flow
800M 460M 510M 410M 550M
Capital expenditures
-110M -77M -71M -71M -68M
Investments
Investing activity other
Total investing cash flows
-180M -1.1B -100M -82M -1.1B
Dividends paid
230M
Net borrowings
540M 1B -32M 150M 360M
Other financing cash flows
Cash flow financing
-320M 580M -1B -260M 610M
Exchange rate effect